|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 117.25 USD | +0.51% |
|
-1.07% | +18.71% |
| 07-15 | BofA Securities Raises Incyte Price Target to $136 From $124 | MT |
| 07-14 | Barclays Adjusts Incyte Price Target to $134 From $117, Maintains Overweight Rating | MT |
Company Valuation: Incyte Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 16,213 | 17,869 | 14,072 | 13,306 | 19,391 | 23,305 | - | - |
| Change | - | 10.21% | -21.25% | -5.44% | 45.73% | 20.18% | - | - |
| Enterprise Value (EV) | 13,865 | 14,630 | 10,416 | 11,148 | 16,293 | 23,305 | 23,305 | 23,305 |
| Change | - | 5.52% | -28.81% | 7.03% | 46.15% | 43.03% | 0% | 0% |
| P/E | 17.2x | 52.8x | 23.7x | 460x | 15.4x | 41.7x | 16x | 16x |
| PBR | 4.32x | 4.09x | 2.71x | 3.88x | 3.79x | - | - | - |
| PEG | - | -0.8x | 0.3x | -4.9x | 0x | -0.7x | 0x | 40.39x |
| Capitalization / Revenue | 5.43x | 5.26x | 3.81x | 3.14x | 3.77x | 4.09x | 3.78x | 3.62x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 4.09x | 3.78x | 3.62x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 34.2x | 11.3x | - |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 26.6x | 10.4x | 9.54x |
| EV / FCF | 0x | 0x | 0x | 0x | - | 25.3x | 14.2x | 12.8x |
| FCF Yield | 3.51% | 4.99% | 3.3% | 1.87% | - | 3.96% | 7.03% | 7.82% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 4.27 | 1.52 | 2.65 | 0.15 | 6.41 | 2.799 | 7.273 | 7.302 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,986 | 3,395 | 3,696 | 4,241 | 5,141 | 5,698 | 6,160 | 6,442 |
| EBITDA 1 | 643.6 | 597.7 | 703.2 | 503.1 | 1,709 | 681.7 | 2,058 | - |
| EBIT 1 | 585.8 | 579.4 | 620.5 | 413.9 | 1,616 | 876 | 2,236 | 2,442 |
| Net income 1 | 948.6 | 340.7 | 597.6 | 32.62 | 1,287 | 579.4 | 1,472 | 1,527 |
| Net Debt | -2,348 | -3,239 | -3,656 | -2,158 | -3,098 | - | - | - |
| Reference price 2 | 73.40 | 80.32 | 62.79 | 69.07 | 98.77 | 116.65 | 116.65 | 116.65 |
| Nbr of stocks (in thousands) | 220,891 | 222,475 | 224,109 | 192,650 | 196,323 | 199,782 | - | - |
| Announcement Date | 2/8/22 | 2/7/23 | 2/13/24 | 2/10/25 | 2/10/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 41.68x | - | - | -.--% | 23.3B | |
| 17.84x | 3.86x | 10.13x | 0.57% | 69.07B | |
| 25.52x | 5.27x | 15.47x | 0.62% | 51.77B | |
| 34.53x | 11.71x | 22.37x | -.--% | 43.63B | |
| -45.77x | 3.23x | 9.55x | 3.34% | 40.89B | |
| 24.82x | 3.61x | 12.09x | -.--% | 30.84B | |
| -7.29x | 10.33x | -6.35x | -.--% | 25.06B | |
| 68.08x | 6.73x | 46.32x | -.--% | 20.92B | |
| 24.41x | 5.19x | 13.22x | -.--% | 16.71B | |
| -36.59x | 17.25x | -47.16x | -.--% | 15.74B | |
| Average | 14.72x | 7.46x | 8.41x | 0.45% | 33.79B | |
| Weighted average by Cap. | 14.79x | 6.52x | 11.22x | 0.62% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- INCY Stock
- Valuation Incyte Corporation
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
